IP Library Granted Patent US 9,132,234
Granted Patent B2
US 9,132,234 · App. 13/760,596 · Granted Sep 15, 2015

Infusion pump systems and methods

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,132,234
App. No.
13/760,596
Granted
Sep 15, 2015
Kind
B2
Abstract

Some embodiments of an infusion pump system can include a controller in which one or more features sets to be provided by the controller are enabled or disabled based upon the particular pump device that is connected to the controller. For example, in some embodiments, one or more advanced features of the controller are available to the user only when a first type of pump device (e.g., having predefined settings stored therein) is connected to the controller, and those advanced features of the controller are disabled when a second type of pump device is connected to the controller.

Claims (34)

1. A method of using a portable infusion pump system, comprising:

selecting an insulin pump device from a set of insulin pump devices comprising at least a first type of insulin pump device and a second type of insulin pump device having the same size and shape as the first type of insulin pump device, wherein the first type of insulin pump device houses a drive system configured to dispense insulin and an internal circuit that stores a first parameter setting indicative of disabling wireless communication, and wherein the second type of insulin pump device houses a drive system configured to dispense insulin and an internal circuit that stores a second parameter setting indicative of enabling wireless communication; and

removably attaching the first type of insulin pump device to a controller device to form an electrical connection between the controller device and the first type of insulin pump device so that the controller device is operable to control the drive system of the first type of insulin pump device to dispense insulin from the first type of insulin pump device, wherein the controller device automatically disables a wireless communication device of the controller device in response to querying via the electrical connection the first parameter setting of the internal circuit housed by the first type of insulin pump device, and wherein the controller device displays a text alert message on a user interface display of the controller device indicating that wireless communication is disabled.

2. The method of claim 1 , further comprising:

detaching the first type of insulin pump device from the controller device; and

removably attaching the second type of insulin pump device to the controller device to form an electrical connection between the controller device and the second type of insulin pump device so that the controller device is operable to control the drive system of the second type of insulin pump device to dispense insulin from the second type of insulin pump device, wherein the controller device automatically enables the wireless communication device of the controller device in response to querying the second parameter setting of the internal circuit housed by the second type of insulin pump device.

3. The method of claim 1 , wherein the controller device displays the text alert message on the user interface of the controller device indicating that wireless communication is disabled until the second type of insulin pump device is removably attached to the controller device.

4. The method of claim 1 , wherein the wireless communication device is housed inside the controller device, and wherein the wireless communication device is configured to wirelessly communicate with at least one of a body-worn glucose monitoring device and a blood glucose meter.

5. The method of claim 1 , wherein the set of insulin pump devices comprises at least the first type of insulin pump device, the second type of insulin pump device, and a third type of insulin pump device, and wherein the controller device automatically changes to a training mode user interface in response to the electrical connection with the third type insulin pump device.

6. The method of claim 1 , wherein the controller device includes control circuitry that is configured to provide an advanced feature set related to continuous glucose monitoring, the advanced feature set including: activation of the wireless communication device to communicate with a body-worn glucose monitoring device, and activation of the user interface display of the controller device to display a glucose level in response to receiving data from the body-worn glucose monitoring device.

7. A method of controlling a portable infusion pump system, comprising:

establishing an electrical connection with an insulin pump device selected from a set of insulin pump devices comprising at least a first type of insulin pump device and a second type of insulin pump device having the same size and shape as the first insulin pump device, wherein the first type of insulin pump device houses an internal circuit that stores a first parameter setting indicative of enabling a first feature set, and wherein the second type of insulin pump device houses an internal circuit that stores a second parameter setting indicative of disabling the first feature set, wherein the selected insulin pump device is removably mounted to a controller device when the electrical connection is established so that the controller device is operable to control dispensation of insulin from the selected insulin pump device;

querying the selected insulin pump device via the electrical connection to determine whether the selected insulin pump device is any one of the first type of insulin pump device or the second type of insulin pump device;

automatically disabling the first feature set provided by the controller device in response to the controller device recognizing that the selected insulin pump device is the second type of insulin pump device; and

outputting a text alert message via the user interface of the controller device indicating that the first feature set is disabled,

wherein outputting the text alert message on the user interface of the controller device comprises displaying a visual message indicating at least one of disablement of wireless communication and disablement of a drive system of the selected insulin pump device.

8. A method of controlling a portable infusion pump system, comprising:

establishing an electrical connection with an insulin pump device selected from a set of insulin pump devices comprising at least a first type of insulin pump device and a second type of insulin pump device having the same size and shape as the first insulin pump device, wherein the first type of insulin pump device houses an internal circuit that stores a first parameter setting indicative of enabling a first feature set, and wherein the second type of insulin pump device houses an internal circuit that stores a second parameter setting indicative of disabling the first feature set, wherein the selected insulin pump device is removably mounted to a controller device when the electrical connection is established so that the controller device is operable to control dispensation of insulin from the selected insulin pump device;

querying the selected insulin pump device via the electrical connection to determine whether the selected insulin pump device is any one of the first type of insulin pump device or the second type of insulin pump device;

automatically disabling the first feature set provided by the controller device in response to the controller device recognizing that the selected insulin pump device is the second type of insulin pump device; and

outputting a text alert message via the user interface of the controller device indicating that the first feature set is disabled,

wherein the controller device includes control circuitry that is configured to provide the first feature set related to continuous glucose monitoring, the first feature set including: activation of a wireless communication device to communicate with a body-worn glucose monitoring device, and activation of a user interface display of the controller device to display a glucose level in response to receiving data from the body-worn glucose monitoring device.

9. A portable infusion pump system, comprising:

a set of insulin pump devices comprising at least a first type of insulin pump device and a second type of insulin pump device having the same size and shape as the first type of insulin pump device, wherein the first type of insulin pump device houses an internal circuit that stores a first parameter setting indicative of disabling wireless communication, wherein the second type of insulin pump device houses an internal circuit that stores a second parameter setting indicative of enabling wireless communication, and wherein each respective insulin pump device of the set of insulin pump devices includes: an insulin pump housing that defines a space to receive insulin, and a drive system to dispense the insulin from the respective insulin pump device when the medicine is received in the space of the insulin pump housing; and

a controller device removably attachable to each respective insulin pump device of the set of insulin pump devices so as to electrically connect with the respective insulin pump device and control dispensation of the insulin from the insulin pump device, wherein the controller device is configured to automatically enable a first feature set provided by the controller device in response to the controller device recognizing that a removably attached insulin pump device of the set of insulin pump devices is the first type of insulin pump device, and wherein the controller device is configured to automatically disable the first feature set provided by the controller device in response to the controller device recognizing that the removably attached insulin pump device of the set of insulin pump devices is the second type of insulin pump device, wherein in response to the controller device recognizing that the removably attached insulin pump device of the set of insulin pump devices is the second type of insulin pump device, the controller device outputs a text alert message via a user interface of the controller device indicating that the first feature set is disabled,

wherein the controller device outputs the text alert message via the user interface by displaying a visual message indicating at least one of disablement of wireless communication and disablement of a drive system of the insulin pump device.

10. A portable infusion pump system, comprising:

a set of insulin pump devices comprising at least a first type of insulin pump device and a second type of insulin pump device having the same size and shape as the first type of insulin pump device, wherein the first type of insulin pump device houses an internal circuit that stores a first parameter setting indicative of disabling wireless communication, wherein the second type of insulin pump device houses an internal circuit that stores a second parameter setting indicative of enabling wireless communication, and wherein each respective insulin pump device of the set of insulin pump devices includes: an insulin pump housing that defines a space to receive insulin, and a drive system to dispense the insulin from the respective insulin pump device when the medicine is received in the space of the insulin pump housing; and

a controller device removably attachable to each respective insulin pump device of the set of insulin pump devices so as to electrically connect with the respective insulin pump device and control dispensation of the insulin from the insulin pump device, wherein the controller device is configured to automatically enable a first feature set provided by the controller device in response to the controller device recognizing that a removably attached insulin pump device of the set of insulin pump devices is the first type of insulin pump device, and wherein the controller device is configured to automatically disable the first feature set provided by the controller device in response to the controller device recognizing that the removably attached insulin pump device of the set of insulin pump devices is the second type of insulin pump device, wherein in response to the controller device recognizing that the removably attached insulin pump device of the set of insulin pump devices is the second type of insulin pump device, the controller device outputs a text alert message via a user interface of the controller device indicating that the first feature set is disabled,

wherein the controller device includes control circuitry that is configured to provide the first feature set related to continuous glucose monitoring, the first feature set including: activation of a wireless communication device to communicate with a body-worn glucose monitoring device, and a display of a glucose level via the user interface of the controller device in response to receiving data from the body-worn glucose monitoring device.

11. A portable infusion pump system, comprising:

a set of insulin pump devices comprising at least a first type of insulin pump device and a second type of insulin pump device having the same size and shape as the first type of insulin pump device, wherein the first type of insulin pump device houses an internal circuit that stores a first parameter setting indicative of disabling wireless communication, wherein the second type of insulin pump device houses an internal circuit that stores a second parameter setting indicative of enabling wireless communication, and wherein each respective insulin pump device of the set of insulin pump devices includes: an insulin pump housing that defines a space to receive insulin, and a drive system to dispense the insulin from the respective insulin pump device when the medicine is received in the space of the insulin pump housing; and

a controller device removably attachable to each respective insulin pump device of the set of insulin pump devices so as to electrically connect with the respective insulin pump device and control dispensation of the insulin from the insulin pump device, wherein the controller device is configured to automatically enable a first feature set provided by the controller device in response to the controller device recognizing that a removably attached insulin pump device of the set of insulin pump devices is the first type of insulin pump device, and wherein the controller device is configured to automatically disable the first feature set provided by the controller device in response to the controller device recognizing that the removably attached insulin pump device of the set of insulin pump devices is the second type of insulin pump device, wherein in response to the controller device recognizing that the removably attached insulin pump device of the set of insulin pump devices is the second type of insulin pump device, the controller device outputs a text alert message via a user interface of the controller device indicating that the first feature set is disabled,

wherein the controller device includes control circuitry that is configured to provide the first feature set related to wireless communication with a blood glucose meter, wherein the controller device automatically activates the first feature set related to wireless communication with a blood glucose meter in response to the controller device recognizing that the removably attached insulin pump device of the set of insulin pump devices is the first type of insulin pump device.

Assignments (18)
SECURITY INTEREST Recorded Jan 10, 2025
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069870/0519 →
SECURITY INTEREST Recorded Jan 10, 2025
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069870/0456 →
SECURITY INTEREST Recorded Sep 30, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069073/0912 →
SECURITY INTEREST Recorded Sep 30, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069074/0001 →
SECURITY INTEREST Recorded Sep 24, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069030/0104 →
SECURITY INTEREST Recorded Sep 24, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069030/0296 →
SECURITY INTEREST Recorded Sep 23, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 069019/0142 →
SECURITY INTEREST Recorded Sep 23, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 069019/0188 →
SECURITY INTEREST Recorded Sep 12, 2024
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 068948/0172 →
SECURITY INTEREST Recorded Sep 12, 2024
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 068948/0324 →
SECURITY AGREEMENT SUPPLEMENT Recorded Sep 7, 2023
From: INSULET CORPORATION
To: MORGAN STANLEY SENIOR FUNDING, INC., AS COLLATERAL AGENT
Reel/Frame 064840/0181 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 7, 2023
From: BIGFOOT BIOMEDICAL, INC.
To: INSULET CORPORATION
Reel/Frame 063909/0826 →
RELEASE OF SECURITY INTEREST Recorded Feb 17, 2023
From: MADRYN FUND ADMINISTRATION, LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 062793/0316 →
SECURITY INTEREST Recorded Feb 10, 2023
From: MADRYN HEALTH PARTNERS, LP
To: MADRYN FUND ADMINISTRATION, LLC
Reel/Frame 062702/0145 →
SECURITY INTEREST Recorded Mar 12, 2021
From: BIGFOOT BIOMEDICAL, INC.
To: MADRYN HEALTH PARTNERS, LP
Reel/Frame 055583/0044 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2015
From: ASANTE SOLUTIONS, INC.
To: ASANTE LLC
Reel/Frame 036049/0175 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 2, 2015
From: ASANTE LLC
To: BIGFOOT BIOMEDICAL, INC.
Reel/Frame 036047/0389 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 22, 2013
From: ESTES, MARK C.; QI, WENKANG; HOPPER, PHILLIP
To: ASANTE SOLUTIONS, INC.
Reel/Frame 030069/0996 →